Join the 'Rhinitis' group to help and get support from people like you. How it works
Rhinitis Blog
| Tweet |
MEDA Announces Dymista Approved by the FDA
Posted 2 May 2012 by Drugs.com
Göteborg, Sweden--(BUSINESS WIRE)--May 2, 2012 – The U.S. Food and Drug Administration (FDA) has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis (SAR). In several clinical studies, Dymista has consistently showed a rapid and more complete symptom relief than standard treatment. "Allergic rhinitis is an increasing problem. Many patients have severe symptoms that cause inability to work and live a normal life. Dymista can offer an effective treatment for patients suffering from these symptoms”, said Anders Lönner, CEO of Meda AB. “The approval of Dymista represents an important achievement for Meda's clinical development groups in the US and Europe. Meda's franchise in the allergy area is strengthened and gives opportunities for the company to grow and establish collaborations in the field. Dymista will be available in the US during the second half of ... Read more
Related support groups: Allergic Rhinitis, Rhinitis
Meda Receives FDA Approval of New Astepro (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
Posted 2 Dec 2009 by Drugs.com
SOMERSET, N.J., Sept. 2 /PRNewswire/ – Meda Pharmaceuticals Inc. today announced that the US Food and Drug Administration (FDA) has approved Astepro (azelastine HCl) Nasal Spray 0.15%, for the treatment of the symptoms of seasonal and perennial allergic rhinitis (SAR and PAR). New Astepro Nasal Spray 0.15% is the first nasal antihistamine to offer convenient once-daily dosing for patients who suffer from seasonal allergies. Astepro Nasal Spray 0.15% relieves rhinitis symptoms, including nasal congestion, without an added decongestant such as pseudoephedrine and is formulated with azelastine, a leading nasal antihistamine in the treatment of seasonal rhinitis in the U.S. The product will be available in pharmacies in early October. Approximately 40 million people in the U.S. suffer from seasonal and perennial allergic rhinitis. Seasonal allergic rhinitis occurs during a specific season, ... Read more
Related support groups: Allergic Rhinitis, Rhinitis
Ask a Question
Further Information
Related Condition Support Groups
Rhinorrhea, Vasomotor Rhinitis, Respiratory Tract Disease
Related Drug Support Groups
Flonase, Veramyst, Bromfed, AlleRx DF, Pannaz, Vazotab, VazoBid, Rescon, Nacon, view more... J-Tan D, AlleRx DF Dose Pack, BroveX PEB, DuraHist D, Durahist PE, Pannaz S, chlorpheniramine/methscopolamine, chlorpheniramine/methscopolamine/phenylephrine, D-Hist D, Brom Tann PE, Extendryl DM, Triall, Dehistine, ScopoHist-PE, SymPak PDX, Dexodryl, CPM-PE-MSC, Dexodryl Suspension, Histatab PH, Ah-chew Ultra, Redur-PCM, AlleRx PE Dose Pack, Chlor-Mes, PCM Allergy, dexchlorpheniramine/methscopolamine/pseudoephedrine, aeroHist, Re-Drylex Jr, DriHist SR, Nohist Plus Jr, RespiVent DF, Duradryl SR, brompheniramine/phenylephrine, BroveX ADT, Extendryl JR, Zotex PE, V-HIST, DriHist, Entre-B, Seradex-LA, carbinoxamine/methscopolamine/pseudoephedrine, chlorpheniramine/dextromethorphan/methscopolamine, J-Tan D SR, Phenyl 15/12mg, Phenyl 7.5/6mg, methscopolamine/phenylephrine, Dallergy PE, Ah-Chew Ultra Tannate, Dimetane Decongestant, Histatab D, Duravent, Nohist Plus, Extendryl Seniors, Alenaze-D NR, Bromaphedrine D, B-Vex D, BPM PE, VaZol-D, Dimaphen Elixir, Extendryl SR, Sinodec, Alacol, Alenaze-D, Rhinabid PD, Bromfed-PD Capsules, Aerohist Plus, AH-Chew, BroveX-D, Ryneze, Rhinabid, Decon-A, Bromfenex PE Pediatric, Bromfenex PE, Dura Tan PE, Prehist D, Extendryl Chews, Omnihist II LA, acetaminophen/diphenhydramine/pseudoephedrine, Norel SD, Chlor-Mes D, AH-Chew II, Ralix, Pseudox M, Dallergy ER, Aerokid, Denaze, WE Allergy, Ex-Histine, DA II, Hista-Vent DA, Dura-Vent/DA, DA Chewable, Liqui-Allergy, Duradryl, Drysec, Drize, Duradryl JR, QV-Allergy